Department of Health and Human Services Grant for Enhancing HIV Services in India under PEPFAR

The Department of Health and Human Services is offering a grant to enhance HIV services in India, specifically targeting People Who Inject Drugs (PWID). Despite existing interventions, HIV prevalence in India remains high, especially in North Eastern states. This grant aims to address gaps in PWID programs, expand coverage of interventions, reduce stigma, improve service provider skills, and increase access to Opioid Substitution Therapy (OST) and HIV testing. Special focus will be on female PWID and their unique challenges, as well as the high prevalence of HIV among spouses of PWID. Deadline for application submission is Oct 15, 2014.

Opportunity ID: 263418

Apply

General Information

Document Type:	Grants Notice
Funding Opportunity Number:	CDC-RFA-GH15-1542
Funding Opportunity Title:	Enhancing the Government of India¿s Capacity through PEPFAR to Scale Up and Improve Comprehensive HIV Service Package Quality for People Who Inject Drugs under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category:	Discretionary
Opportunity Category Explanation:	–
Funding Instrument Type:	Cooperative Agreement
Category of Funding Activity:	Health
Category Explanation:	–
Expected Number of Awards:	1
Assistance Listings:	93.067 — Global AIDS
Cost Sharing or Matching Requirement:	No
Version:	Synopsis 1
Posted Date:	Aug 28, 2014
Last Updated Date:	–
Original Closing Date for Applications:	Oct 15, 2014
Current Closing Date for Applications:	Oct 15, 2014
Archive Date:	Nov 14, 2014
Estimated Total Program Funding:	$0
Award Ceiling:	$1,800,000
Award Floor:	$0

Eligibility

Eligible Applicants:

Others (see text field entitled “Additional Information on Eligibility” for clarification)

Additional Information on Eligibility:

Eligible applicants that can apply for this FOA are listed below:

Government Organizations:
• National Ministries of Health
• State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) .
• American Indian/Alaska Native tribal governments (federally recognized or state-recognized)
• Political subdivisions of States (in consultation with States)

Non-government Organizations:
• American Indian/Alaska native tribally designated organizations
• Alaska Native health corporations
• Tribal epidemiology centers
• Urban Indian health organizations
• Nonprofit with 501C3 IRS status (other than institution of higher education)
• Nonprofit without 501C3 IRS status (other than institution of higher education)
• Research institutions (that will perform activities deemed as non-research)

Colleges and Universities

Community-based organizations

Faith-based organizations

For-profit organizations (other than small business)

Hospitals

Small, minority, and women-owned businesses

All Other eligible organizations

Agency Name:	Centers for Disease Control and Prevention
Description:	Despite the scale up of interventions among People Who Inject Drugs (PWID), HIV prevalence continues to be high in India at 7.1%. Most worrisome is the continued high HIV prevalence in the North Eastern states (NE) of Manipur (12.9%), Mizoram (12.0%) and Meghalaya (6.4%). A qualitative study (2011) carried out to assess gaps in the national PWID program revealed that PWID interventions in India and especially NE states where the epidemic lies are lagging in terms of intensity and coverage of interventions, continued barriers to accessing services, stigma and discrimination, and lack of skills in dealing with PWID among service providers. Another observation by the qualitative study is that most PWIDs have transitioned from non-injecting modes of administration (e.g., smoking or chasing heroin) to injecting (e.g., injecting pharmaceuticals or heroin). Analysis of national program data revealed that Opioid Substitution Therapy (OST) coverage in NE states was 12% (planned target 20%) and retention was also low (59%). Similarly, HIV testing coverage was also low (48%) in NE states. There is scant information on the extent of female PWID and the challenges this group faces accessing services. The estimated number of female PWID is 10,000 and they are concentrated in NE states. HIV testing facility data reveals a prevalence of 7-25% among female PWID. Similarly, HIV prevalence has been reported to be high among spouses of PWID (2.5% to 5%). There are also concerns regarding high reported spousal violence among this population (55%).
Link to Additional Information:	–
Grantor Contact Information:	If you have difficulty accessing the full announcement electronically, please contact: CDC Procurement and Grants Office Technical Information Management Section E-mail: pgotim@cdc.gov Phone: 770-488-2700 Email:pgotim@cdc.gov

Department of Health and Human Services Grant for Enhancing HIV Services in India under PEPFAR

General Information

Eligibility

Additional Information

Version History

Related Documents

Packages

Package 1

Mandatory forms

Optional forms

About the Author: osnqt

Department of Health and Human Services Grant for Enhancing HIV Services in India under PEPFAR

General Information

Eligibility

Additional Information

Version History

Related Documents

Packages

Package 1

Mandatory forms

Optional forms

Share This Post, Choose Your Platform!

About the Author: osnqt